Onkar Singh Selected Research

Onkar Singh Research Topics

Disease

3	Breast Neoplasms (Breast Cancer) 10/2016 - 05/2011
3	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 02/2014 - 06/2011
3	Nasopharyngeal Carcinoma 04/2012 - 06/2011
2	Infections 04/2019 - 01/2012
2	Neoplasms (Cancer) 08/2013 - 12/2005
2	Burns 09/2011 - 01/2011
2	Cicatrix (Scar) 09/2011 - 07/2010
2	Wounds and Injuries (Trauma) 09/2011 - 01/2011
2	Neoplasm Metastasis (Metastasis) 07/2010 - 12/2005
1	Prostatic Neoplasms (Prostate Cancer) 08/2021
1	Anorchia 08/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2020
1	Chronic Disease (Chronic Diseases) 01/2019
1	Alkaptonuria 02/2017
1	Urolithiasis 02/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2016
1	HIV Infections (HIV Infection) 01/2014
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2012
1	Hemorrhage 10/2011
1	Xanthogranulomatous Pyelonephritis 10/2011
1	Contracture 09/2011
1	Amebic Liver Abscess 07/2011
1	Pyonephrosis 01/2011
1	Stroke (Strokes) 12/2010
1	Venous Thromboembolism 12/2010
1	Carcinoma (Carcinomatosis) 07/2010
1	Adenocarcinoma 07/2010
1	Ototoxicity 12/2009
1	Diabetes Mellitus 11/2009
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2009
1	Liver Abscess 05/2009

Drug/Important Bio-Agent (IBA)

3	Tamoxifen FDA LinkGeneric 10/2016 - 05/2011
3	Docetaxel (Taxotere)FDA Link 02/2014 - 06/2011
3	Cytochrome P-450 CYP3AIBA 01/2012 - 05/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2012 - 05/2009
2	Cytochrome P-450 CYP2C19IBA 01/2016 - 05/2011
2	Pharmaceutical PreparationsIBA 08/2013 - 12/2005
1	AndrogensIBA 08/2021
1	SiliconesIBA 04/2019
1	SolutionsIBA 01/2019
1	Homogentisate 1,2-Dioxygenase (Homogentisate 1,2 Dioxygenase)IBA 02/2017
1	Tyrosine (L-Tyrosine)FDA Link 02/2017
1	Homogentisic AcidIBA 02/2017
1	EnzymesIBA 12/2016
1	Human immunodeficiency virus 1 p16 proteaseIBA 12/2016
1	Peptide Hydrolases (Proteases)FDA Link 12/2016
1	N,N-didesmethyl-4-hydroxytamoxifenIBA 01/2016
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2014
1	Anti-Infective Agents (Microbicides)IBA 01/2014
1	Phosphotransferases (Kinase)IBA 08/2013
1	Proteins (Proteins, Gene)FDA Link 08/2013
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2013
1	Imatinib Mesylate (Gleevec)FDA Link 01/2012
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 09/2011
1	SilverIBA 09/2011
1	pazopanib FDA Link 08/2011
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 05/2011
1	Cytochrome P-450 CYP2C9IBA 05/2011
1	4-hydroxy-N-desmethyltamoxifenIBA 05/2011
1	CollagenIBA 01/2011
1	Warfarin (Coumadin)FDA LinkGeneric 12/2010
1	AnticoagulantsIBA 12/2010
1	AminoglycosidesIBA 12/2009
1	Surface-Active Agents (Surfactants)IBA 12/2009
1	SolventsIBA 12/2009
1	BuffersIBA 12/2009
1	FluoroquinolonesIBA 12/2009
1	Emulsifying AgentsIBA 12/2009
1	AntioxidantsIBA 12/2009
1	Aldehyde Reductase (Aldose Reductase)IBA 11/2009
1	SteroidsIBA 09/2009
1	Heparin Cofactor IIIBA 12/2005
1	LigandsIBA 12/2005
1	GlycosaminoglycansIBA 12/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2005
1	Dermatan SulfateIBA 12/2005
1	OligosaccharidesIBA 12/2005
1	CarbohydratesIBA 12/2005

Therapy/Procedure

2	Therapeutics 08/2021 - 12/2005
2	Nephrectomy 10/2011 - 01/2011
2	Catheters 07/2011 - 05/2009
1	Orchiectomy (Orchidectomy) 08/2021
1	Cesarean Section (Caesarean Section) 11/2020
1	Conversion to Open Surgery 10/2011
1	Drug Therapy (Chemotherapy) 08/2011
1	Biological Dressings 01/2011
1	Hysterectomy 07/2010